Guardant Health, Inc.
GH
$85.49
$1.471.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 982.02M | 902.57M | 828.85M | 774.00M | 739.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 982.02M | 902.57M | 828.85M | 774.00M | 739.02M |
| Cost of Revenue | 349.01M | 327.11M | 308.01M | 299.23M | 289.80M |
| Gross Profit | 633.01M | 575.46M | 520.84M | 474.77M | 449.22M |
| SG&A Expenses | 705.12M | 657.31M | 623.46M | 575.87M | 544.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.42B | 1.34B | 1.29B | 1.23B | 1.18B |
| Operating Income | -436.30M | -441.32M | -459.44M | -453.57M | -442.58M |
| Income Before Tax | -417.54M | -397.61M | -412.74M | -415.38M | -435.09M |
| Income Tax Expenses | -1.26M | 1.18M | 1.07M | 1.17M | 1.28M |
| Earnings from Continuing Operations | -416.28 | -398.79 | -413.82 | -416.55 | -436.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -416.28M | -398.79M | -413.82M | -416.55M | -436.37M |
| EBIT | -436.30M | -441.32M | -459.44M | -453.57M | -442.58M |
| EBITDA | -396.56M | -401.18M | -418.11M | -411.66M | -400.20M |
| EPS Basic | -3.31 | -3.21 | -3.35 | -3.38 | -3.56 |
| Normalized Basic EPS | -1.98 | -1.99 | -2.06 | -2.00 | -1.99 |
| EPS Diluted | -3.31 | -3.21 | -3.35 | -3.38 | -3.56 |
| Normalized Diluted EPS | -1.98 | -1.99 | -2.06 | -2.00 | -1.99 |
| Average Basic Shares Outstanding | 501.45M | 496.55M | 494.79M | 493.12M | 490.96M |
| Average Diluted Shares Outstanding | 501.45M | 496.55M | 494.79M | 493.12M | 490.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |